PBYI FY 2022 Earnings — Puma Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

PBYIPuma Biotechnology, Inc.

$311M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$228M-9.9% YoY

Gross Profit

$173M75.8% margin

Operating Income

$24M10.4% margin

Net Income

$2,0000.0% margin

EPS (Diluted)

$0.02

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$23M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$222M

Total Liabilities

$200M

Stockholders' Equity

$22M

Cash & Equivalents

$76M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$228M	$253M	-9.9%
Gross Profit	$173M	$189M	-8.7%
Operating Income	$24M	$1M	+1738.8%
Net Income	$2,000	-$29M	+100.0%